Extract from DT article :
Vaccines ‘highly effective’ against the Indian coronavirus variant
Britain back on course for a full reopening by June 21 after ‘astounding’ real-world data show protection offered by double dose of jabs
By
Steve Bird
;
Christopher Hope,
CHIEF POLITICAL CORRESPONDENT and
Patrick Sawer,
SENIOR NEWS REPORTER
22 May 2021 • 10:30pm
Vaccine success
Britain’s vaccines are “highly effective” against the Indian coronavirus variant, government scientists hailed on Saturday night, putting the country back on course for a full reopening by June 21.
In a marked change in tone, Public Health England (PHE) scientists said the first real-world data showed double doses of Pfizer/BioNTech or AstraZeneca were nearly as effective against the emerging Indian strain as they were against the Kent variant.
The findings, from a study which included more than a thousand people who had contracted the Indian variant, were described as “groundbreaking” by a buoyant Matt Hancock, the Health Secretary, and “astounding” by Nadhim Zahawi, the vaccines minister.
Dr Mary Ramsay, head of immunisation at PHE, urged people to get their “vital” second vaccine as soon as it was offered, saying it provided “maximum protection against all existing and emerging variants”.
Scientists found the Pfizer vaccine was 88 per cent effective against symptomatic disease from the Indian variant from two weeks after the second dose, compared to 93 per cent effective against the Kent strain.
The AstraZeneca vaccine was found to be 60 per cent effective against the Indian strain, compared to 66 per cent against the Kent variant, over the same period.
Vaccines ‘highly effective’ against the Indian coronavirus variant
Britain back on course for a full reopening by June 21 after ‘astounding’ real-world data show protection offered by double dose of jabs
By
Steve Bird
;
Christopher Hope,
CHIEF POLITICAL CORRESPONDENT and
Patrick Sawer,
SENIOR NEWS REPORTER
22 May 2021 • 10:30pm
Vaccine success
Britain’s vaccines are “highly effective” against the Indian coronavirus variant, government scientists hailed on Saturday night, putting the country back on course for a full reopening by June 21.
In a marked change in tone, Public Health England (PHE) scientists said the first real-world data showed double doses of Pfizer/BioNTech or AstraZeneca were nearly as effective against the emerging Indian strain as they were against the Kent variant.
The findings, from a study which included more than a thousand people who had contracted the Indian variant, were described as “groundbreaking” by a buoyant Matt Hancock, the Health Secretary, and “astounding” by Nadhim Zahawi, the vaccines minister.
Dr Mary Ramsay, head of immunisation at PHE, urged people to get their “vital” second vaccine as soon as it was offered, saying it provided “maximum protection against all existing and emerging variants”.
Scientists found the Pfizer vaccine was 88 per cent effective against symptomatic disease from the Indian variant from two weeks after the second dose, compared to 93 per cent effective against the Kent strain.
The AstraZeneca vaccine was found to be 60 per cent effective against the Indian strain, compared to 66 per cent against the Kent variant, over the same period.